This is due to an early programing during cancer development of cancer-associated fibroblast, via IL-1β-secretion and nuclear factor-κB (NF-κB) activation, to sustain a tumor-promoting inflammatory response [63]. The gene discussed is NFKB1; the disease is neoplasm.